The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses

Pharmacogenetics has potential for optimizing use of psychotropics. CYP2D6 and CYP2C19 are two clinically relevant pharmacogenes in the prescribing of antidepressants. Using cases recruited from the Understanding Drug Reactions Using Genomic Sequencing (UDRUGS) study, we aimed to evaluate the clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kee, Ping Siu, Maggo, Simran D. S., Kennedy, Martin A., Chin, Paul K. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988947/
https://www.ncbi.nlm.nih.gov/pubmed/36895946
http://dx.doi.org/10.3389/fphar.2023.1080117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988947/
https://www.ncbi.nlm.nih.gov/pubmed/36895946
http://dx.doi.org/10.3389/fphar.2023.1080117

Ejemplares similares